Bindinglaw

US · guidance

CMS Pub. 100-08, ch. 8, § 8.3.3.1

DME Payment Suspensions (MACs and UPICs)

activein force · 2026-08-25 – presentas-observed

For national payment suspensions involving durable medical equipment (DME) suppliers

that are enrolled in multiple jurisdictions, the following is applicable for DME MACs and

UPICs:

• When CMS suspends payments to a DME supplier, all payments to the

supplier are suspended in all DME jurisdictions if the same Tax Identification

Number is used. The information (whether based on fraud or non-fraud) that

payments should be suspended in one DME jurisdiction is sufficient reason

for payment suspension decisions to apply to the other locations.

• The UPIC that recommends the national payment suspension to CPI shall

become the “Lead” UPIC for the payment suspension if the payment

suspension is approved. The Lead UPIC is responsible for informing the other

UPICs (non-lead UPICs) of the payment suspension being initiated and for the

coordination of the payment suspension activities. CMS suggests that monthly

contractor calls be held to communicate the current activities of the national

suspension by each of the contractors.

• The Lead UPIC is responsible for coordinating and reporting to its BFL, with

a copy to their COR, whether the non-lead UPICs are compliant with the

payment suspension timeframe and activities.

• All non-lead UPICs are responsible for determining an overpayment(s) for its

jurisdiction. Non-lead UPICs shall take into account the findings of the Lead

UPIC and take appropriate measures (prepayment review, etc.) to protect and

safeguard Medicare Trust Fund dollars from being inappropriately paid.

For UPIC-initiated DME payment suspensions:

• Each UPIC shall be responsible for ensuring that the payment suspension edit

has been initiated in its respective DME MAC jurisdiction and has

communicated this to the lead UPIC. If a non-lead UPIC determines that

medical review would not be appropriate in their jurisdiction for subject

provider, the non-lead UPIC shall notify and request permission from their

BFL to opt out of the medical review.

• The Lead UPIC shall create both a CSE record, if not already created, to track

the investigative activities and a PSP record to track the activities specific to

the payment suspension in UCM. The lead UPIC shall check the “lead”

checkbox. Non-lead UPICs shall not create a separate PSP and is responsible

for timely updating the lead UPIC’s PSP with monthly suspended amounts

within their jurisdictions, as well as adding any pertinent comments and/or

documentation.

Non-lead UPICs shall create a CSE and the appropriate administrative action

records to track their activities.

History

(Rev. 13762; Issued: 05-27-26; Effective: 06-29-26; Implementation: 06-29-26)

Provenance

Source
cms.gov
Retrieved
2026-08-25
Edition
iom-2026-08-25
Content hash
48befc3a528d8ef5ac0d1994b093409d8d46afd075f1cb09739f7012f65e6a88
View the official source →

The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.

Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.

Coverage · API docs

Bindinglaw

Point-in-time US law with the receipt attached. Source URL, retrieval time, content hash, and validity dates on every answer.

curl api.binding.law/v1/law/coverage

© 2026 binding.law · a Jubal, Inc. productAttorneys and firms never pay. Ever.